Cohort Study Evaluates Risk of TNF Inhibitor–Induced Psoriasis

The study involved an analysis of TNF inhibitor-induced psoriasis risk in 109,085 patients with RA and IBD enrolled in Danish national registries between 1995 and 2018.
Medscape Medical News